|
GB201811726D0
|
|
Therapeutic compositions
|
|
US2010022442A1
|
|
Compositions and methods for increasing serum antioxidant concentrations, decreasing serum triglyceride levels, inhibiting insulin-receptor signaling activity, increasing serum ghrelin levels, and decreasing serum tnf-alpha levels
|
|
AU2006238853A1
|
|
Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
|
|
CN101228178A
|
|
Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
|
|
US7238662B2
|
|
Alpha 2HS glycoprotein for treatment of cancer and a method for preparation thereof
|
|
TWI316519B
|
|
Method of preparing fetuin to induce apoptosis
|
|
WO0182871A2
|
|
Method of using zinc isotope for therapy and diagnosis of colon cancer
|
|
US6352729B1
|
|
Plant extract that inhibits the release of tumor necrosis factor alpha (TNF-alpha)
|
|
US6312737B1
|
|
Method of inducing apoptosis in cancer cells using an extract of Melothria indica Lou
|
|
TW593335B
|
|
The use of fetuin for the manufacture of a medicament for the treatment of cancer
|
